Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound)
this process aided in the production of mucin, an out-of-control cytokine secretion, and other inflammatory responses, resulting in the progression of UC (Gustin et al
His Cleveland Clinic colleague Leslie Cho, MD, Section Head of Preventive Cardiology, notes that its essential to keep in mind an even broader point that more patients stand to benefit from initiation of GLP-1 receptor agonist therapy of any kind
Effect of concentrated apple extract on experimental colitis induced by acetic acid
"And people look at the transformative results of pharmaceutical-grade peptides and wrongly assume that all peptides are inherently safe." Social media is awash with adverts and videos of influencers injecting themselves with various concoctions of peptides that are sold for research purposes only
Always focused on supporting muscle, energy and overall wellbeing alongside GLP 1 use